File Download

There are no files associated with this item.

  Links for fulltext
     (May Require Subscription)
Supplementary

Conference Paper: Changing disease burden and management issues for esophageal cancer in the Asia-Pacific region

TitleChanging disease burden and management issues for esophageal cancer in the Asia-Pacific region
Authors
KeywordsAdenocarcinoma
Barrett's esophagus
Endoscopic therapy
Epidemiology
Esophageal neoplasm
Multimodality treatment
Squamous cell carcinoma
Surgery
Issue Date2002
PublisherWiley-Blackwell Publishing Asia. The Journal's web site is located at http://www.blackwellpublishing.com/journals/JGH
Citation
Journal Of Gastroenterology And Hepatology, 2002, v. 17 n. 4, p. 374-381 How to Cite?
AbstractThe changing epidemiology of esophageal cancer in developed countries is from squamous cell type to adenocarcinomas arising from Barrett's epithelium and the gastric cardia. This has implications for management of this disease. Earlier diagnosis of cancer from screening high-risk patients with Barrett's esophagus is potentially possible, and mucosal ablation together with acid-suppressive therapies have been investigated to revert Barrett's epithelium in its premalignant stage. When a cancer has developed, the strategies of staging methodology and surgical approaches also differ from those applicable for squamous cell cancers located in more proximal locations of the esophagus. By contrast, in the Asia-Pacific region (with the exceptions of Australia and New Zealand), squamous cell cancers in the middle portion of the esophagus remain the main cell type seen. An overall increase in life expectancy has led to more elderly patients presenting with carcinoma of the esophagus. This is of particular importance when surgical resection is contemplated. Advances in surgical management, multimodality programs, and endoscopic therapies are most marked in recent years. Treatment for patients with esophageal cancer should be individualized. The choice depends on expertise and facilities available, tumor and patient factors, and local economics. © 2002 Blackwell Publishing Asia Pty Ltd.
Persistent Identifierhttp://hdl.handle.net/10722/173556
ISSN
2015 Impact Factor: 3.322
2015 SCImago Journal Rankings: 1.190
ISI Accession Number ID
References

 

DC FieldValueLanguage
dc.contributor.authorLaw, Sen_HK
dc.contributor.authorWong, Jen_HK
dc.date.accessioned2012-10-30T06:32:57Z-
dc.date.available2012-10-30T06:32:57Z-
dc.date.issued2002en_HK
dc.identifier.citationJournal Of Gastroenterology And Hepatology, 2002, v. 17 n. 4, p. 374-381en_US
dc.identifier.issn0815-9319en_HK
dc.identifier.urihttp://hdl.handle.net/10722/173556-
dc.description.abstractThe changing epidemiology of esophageal cancer in developed countries is from squamous cell type to adenocarcinomas arising from Barrett's epithelium and the gastric cardia. This has implications for management of this disease. Earlier diagnosis of cancer from screening high-risk patients with Barrett's esophagus is potentially possible, and mucosal ablation together with acid-suppressive therapies have been investigated to revert Barrett's epithelium in its premalignant stage. When a cancer has developed, the strategies of staging methodology and surgical approaches also differ from those applicable for squamous cell cancers located in more proximal locations of the esophagus. By contrast, in the Asia-Pacific region (with the exceptions of Australia and New Zealand), squamous cell cancers in the middle portion of the esophagus remain the main cell type seen. An overall increase in life expectancy has led to more elderly patients presenting with carcinoma of the esophagus. This is of particular importance when surgical resection is contemplated. Advances in surgical management, multimodality programs, and endoscopic therapies are most marked in recent years. Treatment for patients with esophageal cancer should be individualized. The choice depends on expertise and facilities available, tumor and patient factors, and local economics. © 2002 Blackwell Publishing Asia Pty Ltd.en_HK
dc.languageengen_US
dc.publisherWiley-Blackwell Publishing Asia. The Journal's web site is located at http://www.blackwellpublishing.com/journals/JGHen_HK
dc.relation.ispartofJournal of Gastroenterology and Hepatologyen_HK
dc.subjectAdenocarcinomaen_HK
dc.subjectBarrett's esophagusen_HK
dc.subjectEndoscopic therapyen_HK
dc.subjectEpidemiologyen_HK
dc.subjectEsophageal neoplasmen_HK
dc.subjectMultimodality treatmenten_HK
dc.subjectSquamous cell carcinomaen_HK
dc.subjectSurgeryen_HK
dc.subject.meshAsia - Epidemiologyen_US
dc.subject.meshChemotherapy, Adjuvanten_US
dc.subject.meshDeveloping Countriesen_US
dc.subject.meshEndoscopy, Digestive Systemen_US
dc.subject.meshEsophageal Neoplasms - Epidemiology - Therapyen_US
dc.subject.meshEsophagus - Surgeryen_US
dc.subject.meshHumansen_US
dc.subject.meshIncidenceen_US
dc.subject.meshNeoadjuvant Therapyen_US
dc.subject.meshPacific Islands - Epidemiologyen_US
dc.subject.meshWestern Worlden_US
dc.titleChanging disease burden and management issues for esophageal cancer in the Asia-Pacific regionen_HK
dc.typeConference_Paperen_HK
dc.identifier.emailLaw, S: slaw@hku.hken_HK
dc.identifier.emailWong, J: jwong@hkucc.hku.hken_HK
dc.identifier.authorityLaw, S=rp00437en_HK
dc.identifier.authorityWong, J=rp00322en_HK
dc.description.naturelink_to_subscribed_fulltexten_US
dc.identifier.doi10.1046/j.1440-1746.2002.02728.xen_HK
dc.identifier.pmid11982715-
dc.identifier.scopuseid_2-s2.0-0036091660en_HK
dc.identifier.hkuros71422-
dc.relation.referenceshttp://www.scopus.com/mlt/select.url?eid=2-s2.0-0036091660&selection=ref&src=s&origin=recordpageen_HK
dc.identifier.volume17en_HK
dc.identifier.issue4en_HK
dc.identifier.spage374en_HK
dc.identifier.epage381en_HK
dc.identifier.isiWOS:000176188700005-
dc.publisher.placeAustraliaen_HK
dc.identifier.scopusauthoridLaw, S=7202241293en_HK
dc.identifier.scopusauthoridWong, J=8049324500en_HK

Export via OAI-PMH Interface in XML Formats


OR


Export to Other Non-XML Formats